Safety and Efficacy of HO/02/02 20µg vs. SoC (Aloe Vera) to Reduce Radiation Dermatitis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
This is a single-center, open-label, randomized, prospective study evaluating the safety and efficacy of HO/02/02 20µg topically applied daily for 15 minutes (with gauze) on treatment fields vs. standard of care (SoC), Aloe Vera treatment
Epistemonikos ID: 6a258a8d00c166f89d5a2da2da3c6264e62c3702
First added on: May 11, 2024